Master Students 2025
6 master students finish their degree in Biochemistry and Molecular Biology or Biomedicine with projects in our lab.
Ida Emilie Jørgensen - exploring the function of the RBM12 protein and mutations in RBM12 in relation to disease.
Lærke Borgen Mikkelsen - exploring SSO-based modulation of LRRK2 gene expression in Parkinson's Disease
Inverna Therapeutics
Inverna Therapeutics is a biotech company established in 2025 as a spin-off of the RNA splicing and disease research group.
Inverna Therapeutics is dedicated to developing transformative RNA therapeutics based on RNA splicing modulation.